Biotech Company Reports Promising Results In ‘Kick And Kill’ HIV Treatment

The firm says its method has reduced latent HIV in 17 patients by an average of 40 percent. In other news, public health officials want to know why a drug that has proven effective at preventing HIV is not being used.